Company
Freecurve
predictive molecular simulations to advance drug discovery, energy, and materials design
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Founded with Michael Levitt, we generate correct, predictive Boltzmann ensembles from first principles. Our simulations predict both molecular structure and interactions.
Loading relationship preview